Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06731426

Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion

Conditions: OCD

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 83
Sponsor: Han Joo Lee

Location: UWM Anxiety Disorders Laboratory Milwaukee Wisconsin

Summary

Thought-Action-Fusion (TAF) is a cognitive bias that posits (1) having unwanted thoughts is morally equivalent to acting upon the thoughts (TAF-Moral; e.g., "Thinking about harming a child is as immoral as actually harming a child") and (2) having unwanted thoughts will increase the likelihood of the thoughts happening in real life (TAF-Likelihood; e.g., "My mother will get into a car accident, because I thought about it"). Given its central role in the development and maintenance of OCD, TAF has emerged as a potential treatment target for obsessive-compulsive disorder (OCD). Previous research has demonstrated that TAF is indeed a malleable construct. This study aims to examine the effects of a multi-session, personalized cognitive bias modification (CBM) for thought-action-fusion (TAF) on improving obsessive-compulsive (OC) symptoms in a college sample.

Eligibility Criteria

Inclusion Criteria: * A score of 18 or higher on the Dimensional Obsessive-Compulsive Scale (DOCS) * Aged 18 or higher * Access to a mobile device (i.e., smartphone) Exclusion Criteria: * Self-reported visual impairment that cannot be adjusted and will prevent them from clearly recognizing words and pictures on mobile screen * Self-reported history of a bipolar disorder or psychotic disorder on a Diagnostic History Scale (DHS) * Inability to adequately understand the study procedure as determined by the responses to comprehension questions provided at the time of the consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06731426). StuddyBuddy aggregates publicly available trial information.